Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 11Interventional 3

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Adrenal incidentaloma × Clear all
NCT07361874 2026-03-27

IMPACT-MACS

University of Texas Southwestern Medical Center

Phase NA Recruiting
75 enrolled

Adrenal incidentaloma, ACTH Syndrome, Ectopic, Cushing Syndrome, Insulin Resistance, Weight Loss

NCT02364089 2023-07-20

CHIRACIC

University Hospital, Bordeaux

Phase NA Completed
78 enrolled

Adrenal incidentaloma, Hypertension, Metabolic Syndrome

NCT01676025 2017-10-06

PRA

Seoul National University Hospital

Phase NA Completed
83 enrolled
Endocrine

Adrenal incidentaloma, Adrenal Gland Diseases, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡